Atlas FDA

The OptiVantage DH Injection System is a contrast delivery system and is designed to inject radiopaque contrast media in

FDA device recall Z-1694-2008 · posted 2008-08-15 · Terminated

Recall details

Recalling firm
Mallinckrodt Inc
Reason for recall
Screws can begin to loosen and shear off to the point of the J-Bow falling from the suspension system. This may cause injury to patients or hospital staff.
Action taken
On April 18, 2008, Mallincrodt Inc. issued an Urgent Device Correction letter informing customers to check their inventory, and determine if they have any defective system units. If they observe any loose screws, sheared screws and/or elongated opening(s) around the screws, they are to immediately take the system out of service and contact the firm's service representative. Covidien's customers were all asked to inspect their inventories and to complete an 'Effectiveness Check Return Form' whether or not the product is defective. However, only those system units observed to have loose screws, sheared screws, and/or elongated openings around the screws, will be scheduled to receive correction by a Covidien Service Representative.
Root cause
Component design/selection
Status
Terminated
Product code
IZQ
Quantity affected
783 Units
Distribution
Product is distributed in the US throughout the following states: AL, AR, AZ, CA, CO ,CT, DC, FL, GA, HI, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NE, NJ, NM, NV, NY, OH, OR, PA, RI, SC
Date initiated
2008-04-07
Date posted
2008-08-15
Date terminated
2011-05-20
Location
Cincinnati, OH

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
OPTIVANTAGE DH INJECTOR SYSTEM WITH ENHANCED COMMUNICATION (K063503)Mallinckrodt Inc., Liebel-Flarsheim Business2007-04-27